Literature DB >> 8493532

Identifying strategies for immune intervention.

A Lanzavecchia1.   

Abstract

In recent years the molecular basis of antigen recognition by T cells has been unraveled and the various pathways that control T cell activation and functional specialization have been defined. Consequently, it is now possible to delineate various strategies for intervention with the immune system to design protective vaccines, to induce an effective response to tumor antigens, and to control graft rejection and autoimmune diseases.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8493532     DOI： 10.1126/science.8493532

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  19 in total

1.  Deregulated cytokine network and defective Th1 immune response in multiple myeloma.

Authors:  M A Frassanito; A Cusmai; F Dammacco
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 2.  Gene therapy in the treatment of ocular inflammation.

Authors:  K Csaky; R Nussenblatt
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

Review 4.  Recent advances in immunobiology of brain tumors.

Authors:  M Tada; N de Tribolet
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

5.  Inflammatory mediators increase surface expression of integrin ligands, adhesion to lymphocytes, and secretion of interleukin 6 in mouse Sertoli cells.

Authors:  A Riccioli; A Filippini; P De Cesaris; E Barbacci; M Stefanini; G Starace; E Ziparo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 6.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

7.  Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.

Authors:  S Jurcevic; C Praud; H L Coppin; A Bertrand; S Ricard; M Thomsen; F Lakhdar-Ghazal; C De Preval
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 8.  Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant.

Authors:  T Jones; A Stern; R Lin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

9.  Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta.

Authors:  G R Peplinski; K Tsung; E D Whitman; J B Meko; J A Norton
Journal:  Ann Surg Oncol       Date:  1995-03       Impact factor: 5.344

Review 10.  Generation of dendritic cell-based vaccines for cancer therapy.

Authors:  G Reinhard; A Märten; S M Kiske; F Feil; T Bieber; I G H Schmidt-Wolf
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.